ArticleMolecular genetics and metabolism reports2022

Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3.

Ni-Chung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.